Purecore Closes $3.52M Oversubscribed Non-Brokered Private PlacementGlobeNewsWire · Oct 19, 2026
Purecore Upsizes Non-Brokered Private Placement to $3.5MGlobeNewsWire · Oct 15, 2026
Purecore Announces Up to $2.5 Million Non-Brokered Private PlacementGlobeNewsWire · Oct 2, 2026
PURE Bioscience (OTCMKTS:PURE) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?Defense World · Sep 2, 2026
PURE HomeRiver Deepens Its Commitment to AppFolio to Power the Next Phase of Its GrowthGlobeNewsWire · Aug 26, 2026
Purecore Provides Corporate Update Highlighting Execution Across Uranium, Copper and Capital MarketsGlobeNewsWire · Aug 26, 2026PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products.